Inventor · disambiguated record
James J. Hagan
Also filed as: HAGAN JAMES · HAGAN JAMES J · HAGAN JAMES JOSEPH
5 granted patents·5 pending applications·439 citations·filing 1994–2009
86Inventor score
Top patents by PatentIndex Score
10 records- 0196US5846519AMethod for imaging mammalian tissue using 1-substituted-1,4,7-tricarboxymethyl-1,4,7,10-tetraazacyclododecane and analogsBRACCO DIAGNOSTICS INC·Filed 1995·Granted Dec 8, 1998·110 cites·19 claims
- 0296US5474756AMethod for imaging mammalian tissue using 1-substituted-1,4,7-tricarboxymethyl-1,4,7,10-tetraazacyclododecane and analogsBRACCO DIAGNOSTICS INC·Filed 1994·Granted Dec 12, 1995·130 cites·3 claims
- 0395US6143274AMethod for imaging and radiopharmaceutical therapy using 1-substituted-4,7,10-tricarboxymethyl-1,4,7,10-tetraazacyclododecane and analogsFiled 1995·Granted Nov 7, 2000·140 cites·186 claims
- 0485US5674470AMethod for imaging mammalian tissue using 1-substituted- 4,7,10-tricarboxymethyl-1,4,7,10-tetraazacyclododecane and analogsBRACCO DIAGNOSTICS INC·Filed 1995·Granted Oct 7, 1997·59 cites·55 claims
- 0555US2009281078A1Combination of sabcomeline with a neuroleptic agent to treat psychotic disordersROUTLEDGE CAROL·Filed 2009·Application pending·0 cites
- 0655US2008081804A1Combination of Sabcomeline with a Neuroleptic Agent to Treat Psychotic DisordersROUTLEDGE CAROL·Filed 2005·Application pending·0 cites
- 0747US2008306043A1Sabcomeline Alone or Combined with a Mood Stabilising or Antimanic Agent to Treat Bipolar DisordersROUTLEDGE CAROL·Filed 2005·Application pending·0 cites
- 0845US2007270428A1Use of Cyclooxygenase-2 Inhibitors for the Treatment of Depressive DisordersHAGAN JAMES·Filed 2004·Application pending·0 cites
- 0936US2007142411A1Use of cyclooxygenase-2 selective inhibitors for the treatment of schizophrenic disordersHAGAN JAMES·Filed 2004·Application pending·0 cites
- 1023US6664229B2Methods for treatment using novel ligands of the neuropeptide receptor HFGAN72SMITHKLINE BEECHAM PLC·Filed 1998·Granted Dec 16, 2003·0 cites·2 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →